Why do Czechs lack Omega-3? Alarming numbers and what to do about it

Here is a number worth sitting with for a moment: 3.56. That is the mean Omega-3 index recorded across the Czech population in a landmark study — a figure that places the country firmly in the "very low" category on the global scale. What makes this result genuinely alarming is not just how low it is, but how consistent it is. It does not matter whether you live in Prague or in a small village in the South Moravian countryside. The numbers are essentially the same. Geography, it turns out, is not your problem. Diet is.

This is a data-driven wake-up call for one of Central Europe's most Omega-3 deficient populations — and more importantly, a practical guide to what you can actually do about it.

What the Omega-3 index actually tells you

Before we get into the Czech-specific data, it is worth understanding what the Omega-3 index (O3I) actually measures. It represents the combined percentage of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) as a proportion of all fatty acids in red blood cell membranes. Because red blood cells turn over roughly every 120 days, this figure reflects your dietary intake over the past three to four months — making it a reliable, objective biomarker rather than a dietary estimate based on self-reporting.

The scale runs roughly as follows: below 4% is considered very low and associated with significantly elevated cardiovascular risk; 4–6% is low; 6–8% is moderate; and above 8% is the desirable range associated with optimal cardiovascular and brain health outcomes. Research has consistently linked higher O3I values with reduced risk of coronary artery disease, lower triglyceride levels, improved cognitive function, and better inflammatory regulation.

So when Czech researchers from the Institute of Physiology of the Czech Academy of Sciences published their findings — a population mean O3I of 3.56%, with a minimum recorded value of just 1.12% — it was not a subtle warning. It was a clear public health signal that the country's relationship with Omega-3 fatty acids is broken.

The study that changed the conversation

The QUALITAS study compared blood samples from 476 residents of Prague with 388 people from rural and industrialised regions — a total of 864 participants. The working hypothesis was logical: surely people in urban areas, with better access to diverse food options and higher purchasing power, would show better Omega-3 status than those in rural areas with more traditional, land-based diets. This hypothesis was completely disproved.

There was no statistically meaningful difference between the two groups. The one variable that did move the needle was behavioural — people who reported eating fish regularly or taking Omega-3 supplements consistently showed higher index values. But even among those individuals, the figures remained below optimal ranges for most participants. In other words, the Czech population is not just lacking Omega-3; it is lacking it across the board, regardless of socioeconomic context, geographic setting, or access to food diversity.

This finding matters because it dismantles a comfortable excuse. You cannot point to where you live and blame limited access. The problem is cultural and dietary, and it is widespread.

Why Central Europe is the world's Omega-3 weak spot

The Czech Republic does not sit in isolation here. Central Europe as a whole has been identified in global surveys as having among the lowest EPA and DHA blood levels on the planet. The region is classified as "very low" in international Omega-3 mapping studies — placing it alongside nations far more associated with nutritional deficiency, which should be sobering context for a region that considers itself well-nourished.

The driver is not hard to identify: fish consumption in Central Europe hovers between 6 and 8 kg per person per year, which translates to less than one portion of fish per week on average. Compare that to the EU average, which Central European countries consume at roughly half the rate, or to fish-rich nations like Japan, South Korea, Iceland, and Norway — all of which record desirable O3I values above 8%. Meanwhile, terrestrial meat consumption in the region sits at 64–83 kg per capita per year, creating a profoundly skewed ratio of Omega-6 to Omega-3 fatty acids.

The Czech diet, built around pork, beef, bread, and dairy, is not inherently unhealthy in every respect. But it is structurally almost devoid of the long-chain marine fatty acids that human physiology genuinely needs. And unlike some nutrients, Omega-3 EPA and DHA cannot be meaningfully manufactured by the body from plant-based precursors like ALA (found in flaxseed and walnuts). The conversion rate is notoriously inefficient — often below 5% — which means plant sources alone cannot solve the problem.

What does this actually mean for health?

Chronically low Omega-3 status is not a benign condition. Cardiovascular disease remains the leading cause of death in the Czech Republic, and while causality is complex, the relationship between suboptimal EPA and DHA levels and cardiac risk is well-established in the scientific literature.

Multiple studies have found that individuals with an O3I below 4% face a significantly higher risk of fatal cardiac events compared to those above 8%.

Beyond the heart, DHA is the primary structural fatty acid of the brain and retina. Long-term insufficiency is associated with faster cognitive decline with age, impaired mood regulation, and reduced visual function. EPA, meanwhile, plays a central role in managing systemic inflammation — a process implicated in everything from metabolic syndrome to depression. In short, Omega-3 deficiency is not a niche issue for fitness enthusiasts. It is a population-level risk factor that touches virtually every chronic disease category.

What to actually do about it: a practical framework

The good news — and there is genuine good news here — is that Omega-3 status is highly responsive to dietary and supplemental intervention. The body updates its red blood cell fatty acid profile continuously, which means meaningful improvements can be measured within weeks to months of changing your intake. Here is how to approach it practically.

Eat more fatty fish, and eat it strategically. Mackerel, herring, sardines, and salmon are among the highest-yield sources of combined EPA and DHA. Two to three portions of fatty fish per week — each roughly 100–150g — can make a real difference to your O3I. For context, even Czech clinical trial participants who ate fish at least twice per week showed meaningfully higher index values than those eating it less than once per month.

Supplement with a high-quality, tested product. For most people in the Czech Republic, diet alone will not be sufficient to reach an O3I above 8% without consistent, meaningful supplementation. Look for a product that clearly lists the EPA and DHA content per serving (not just total fish oil), delivers at least 1,000mg of combined EPA+DHA daily, and carries third-party certification for purity and potency. To raise an O3I from the 4% range to 8%, research suggests an additional daily intake of approximately 1.4g of EPA and DHA is needed. The molecular form matters too — choose triglyceride or phospholipid-based forms over ethyl esters for better absorption.

Test your baseline. At-home Omega-3 index testing via blood spot cards is now widely accessible and inexpensive. Knowing your actual number — rather than guessing — fundamentally changes how you approach correction and allows you to track real progress.

Address the ratio, not just the total. Reducing excessive Omega-6 intake from refined vegetable oils (sunflower, corn, and soybean oil are particularly high) is as important as increasing Omega-3. The two compete for the same metabolic pathways, so flooding your system with Omega-6 blunts the effect of even adequate Omega-3 intake.

If you follow a plant-based diet, choose algae oil. Flaxseed, walnuts, and chia seeds provide ALA, not EPA or DHA. Algae oil — the original source of marine Omega-3 in the food chain — delivers genuine EPA and DHA without relying on fish. Advances in algae cultivation have made this option far more potent and accessible than it was even five years ago.

The bottom line

A mean Omega-3 index of 3.56% is not a nuanced finding that requires careful interpretation. It is a clear deficit, distributed broadly and consistently across an entire population, with real implications for long-term health outcomes. The encouraging part is that Omega-3 status is one of the most correctable nutritional imbalances there is — but only if you know about it and actually act on it.

The data is in. The question now is what you do with it.

References

• Harris, W. S., & Von Schacky, C. (2004). The omega-3 index: A new risk factor for death from coronary heart disease? Preventive Medicine, 39(2), 212–220. https://doi.org/10.1016/j.ypmed.2004.02.030
• Mozaffarian, D., & Wu, J. H. (2011). Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology, 58(20), 2047–2067. https://doi.org/10.1016/j.jacc.2011.06.063
• Oseeva, M., Paluchová, V., Žáček, P., Janovska, P., Mráček, T., Rossmeisl, M., Hamplovová, D., Cadova, N., Stohanzlova, I., Flachs, P., Kopecký, J., & Kuda, O. (2019). Omega-3 index in the Czech Republic: No difference between urban and rural populations. Chemistry and Physics of Lipids, 220, 23–27. https://doi.org/10.1016/j.chemphyslip.2019.02.007
• Schuchardt, J. P., & Hahn, A. (2013). Bioavailability of long-chain omega-3 fatty acids. Prostaglandins, Leukotrienes and Essential Fatty Acids, 89(1), 1–8. https://doi.org/10.1016/j.plefa.2013.03.010
• Schuchardt, J. P., Cerrato, M., Ceseri, M., DeFina, L. F., Delgado, G. E., Gülmez, T., Hahn, A., Howard, B. V., Kris-Etherton, P., Latini, R., Marz, W., Mozaffarian, D., Orringer, C. E., Superko, H. R., Thijs, L., Tintle, N., Vasan, R. S., & Harris, W. S. (2024). Omega-3 world map: 2024 update. Progress in Lipid Research, 95, 101286. https://doi.org/10.1016/j.plipres.2024.101286
• Stark, K. D., Van Elswyk, M. E., Higgins, M. R., Weatherford, C. A., & Salem, N. (2016). Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Progress in Lipid Research, 63, 132–152. https://doi.org/10.1016/j.plipres.2016.05.001
• Swanson, D., Block, R., & Mousa, S. A. (2012). Omega-3 fatty acids EPA and DHA: Health benefits throughout life. Advances in Nutrition, 3(1), 1–7. https://doi.org/10.3945/an.111.000893
• Troesch, B., Eggersdorfer, M., Laviano, A., Rolland, Y., Smith, A. D., Warnke, I., Weimann, A., & Calder, P. C. (2020). Expert opinion on benefits of long-chain omega-3 fatty acids (DHA and EPA) in aging and clinical nutrition. Nutrients, 12(9), 2555. https://doi.org/10.3390/nu12092555
• Ulven, S. M., & Holven, K. B. (2015). Comparison of bioavailability of krill oil versus fish oil and health effect. Vascular Health and Risk Management, 11, 511–524. https://doi.org/10.2147/VHRM.S85165
• von Schacky, C. (2014). Omega-3 index and cardiovascular health. Nutrients, 6(2), 799–814. https://doi.org/10.3390/nu6020799